Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

ABSTRACT: RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody F19 in treating patients who have advanced or metastatic cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2003478 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR